Caribou Biosciences

CRBUNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$44.202 M

$0.41 -7.22%

Close of 6 Nov 2026

As of 6 Nov 2026, Caribou Biosciences (CRBU) has a market capitalization of $44.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$11.2M

#3109 by revenue

Earnings

-$148.1M

Loss-making

Shares outstanding

108,036,729

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#126Instil BioTIL$47.9M
#127ImageneBioIMA$46.2M
#128Caribou BiosciencesCRBU$44.2M
#129LeonaBioLONA$40.8M
#130ExozymesEXOZ$38.2M

What if Caribou Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$263,385.21

Per share 638,819× higher

Bitcoin $1.53T

$14,251.32

Per share 34,565× higher

Apple $5.02T

$46,785.74

Per share 113,475× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Caribou Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.